SightfileU.S. market data from official filings

AMERICAN SHARED HOSPITAL SVC (AMS)

Name: AMERICAN SHARED HOSPITAL SVC (AMS) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000744825 · EDGAR filings · Updated 2026-07-28

AMERICAN SHARED HOSPITAL SVC (AMS) has reported institutional ownership of 15.0%, with 21 institutional managers holding positions valued at $1.43M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership

15.0%

Institutional managers

Reported 13F value

$1.43M

Insider activity

2 trans.

$0 net flat

Data flags

3 active

from SEC filings

Filings this week (2)

2026-07-28 — Current report (8-K) filed
2026-07-24 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-16 — Initial insider ownership filed (Form 3)
2026-07-13 — Current report (8-K) filed
2026-06-30 — Current report (8-K) filed
2026-06-25 — SCHEDULE 13D/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AMERICAN SHARED HOSPITAL SVC has 21 institutional holders and institutional ownership of 15.0%.

Insider activity

Insiders reported 2 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2026-06-04 (recurring since 2026-06-04) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-14 (recurring since 2026-01-16) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2026-01-02 (recurring since 2026-01-02) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Turn Therapeutics Inc (TTRX) · BioVie Inc (BIVI) · QUINCE THERAPEUTICS (QNCX) · MINK THERAPEUTICS INC (INKT) · NUTRIBAND INC (NTRB) · CDT EQUITY INC (CDT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.